Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Psychiatric Drugs Send 90,000 to Emergency Rooms Each Year—Mental Health Watchdog Cites Need for Consumers to Search Psychiatric Drug Database for Documented Risks
  • USA - English


News provided by

Citizens Commission on Human Rights

Sep 08, 2014, 09:00 ET

Share this article

Share toX

Share this article

Share toX


Los Angeles, California (PRWEB) September 08, 2014 -- A recent JAMA Psychiatry study revealed that between 2009 and 2011, there were an estimated 267,000 emergency room visits because of adverse drug events from psychiatric drugs such as overdose, excessive sleepiness and head injuries. Over 19% of these emergency room visits resulted in patient hospitalization.[1] The lead author of the JAMA study suggested the need for caution, increased surveillance, and reduced use of psychiatric drugs, and even encouraged alternative treatments.[2]

The JAMA study reinforces the need for full disclosure and, with 79 million Americans taking at least one psychiatric drug, the study's limited data provides an honest appraisal of the growing problem of adverse events associated with psychiatric drugs.

Post this

The JAMA report, first released in July, breaks down the adverse drug events by class of drug, reporting that nearly 78,000 of the emergency room visits were due just to sedatives/anxiolytics, antidepressants and antipsychotics. Other drugs causing such reactions included lithium salts and stimulants.[3]

Citizens Commission on Human Rights (CCHR), the leading mental health watchdog, says this data should be of no surprise given the ever-increasing use of psychiatric drugs:

• According to IMS Health’s Total Patient Tracker database, psychiatric drug use now includes even the youngest of the nation's population. In fact, in 2013, more than one million American children between the ages of 0 and 5 were prescribed psychiatric drugs.[4]
• For all ages, more than ten million Americans took ADHD drugs, 41 million took antidepressants, more than six and a half million took antipsychotics and 36 million took anti-anxiety drugs.[4]
• Seventy-nine million Americans, one-in-four, are currently prescribed psychiatric drugs.[4]
In an effort to provide accurate information about the documented risks associated with psychiatric drugs, CCHR last year launched a comprehensive website and enhanced psychiatric drug database.

This database could not have been more timely or user friendly. According to the Food and Drug Administration (FDA), between 2004 and 2012, there were more than five hundred thousand adverse reactions from psychiatric drugs reported to the federal agency.[5] These reports are just the tip of the iceberg, as the FDA admits that only about 1% of serious adverse events are actually reported.[6]

More telling, however, is that most Americans are unaware of the national and international regulatory agency warnings on most psychiatric drugs. For example, there are 134 drug regulatory warnings associated with antidepressants, 44 regulatory warnings for ADHD drugs and 25 regulatory warnings for anti-anxiety drugs.[7]

CCHR's website and drug database provides a wealth of information for families, including adverse side effects, the number of studies showing adverse effects of specific drugs and the FDA's data on adverse drug events. In short, the mental health watchdog has taken very complex data from a number of sources and provided an easy, user-friendly, format not available from the FDA or any other regulatory agency.

While many of the psychiatric drugs long have been branded with the FDA's "black box" warning—the federal agency's most serious warning—too often the adverse reactions associated with psychiatric drugs are down played and physician follow-up is spotty, leaving those taking psychiatric drugs to find accurate information on their own.

CCHR says that, “the JAMA study reinforces the need for full disclosure and, with 79 million Americans taking at least one psychiatric drug, the study's limited data at least provides an honest appraisal of the growing problem of adverse events associated with psychiatric drugs.”

For those concerned about the dangers associated with psychiatric drugs, the following links provide a complete list of all documented side effects of the following categories of psychiatric drugs:

ADHD Drug Side Effects
Antidepressant Drug Side Effects
Antipsychotic Drug Side Effects
Anti-anxiety Drug Side Effects

Read full article here.

About Citizens Commission on Human Rights: CCHR is a non-profit, non-political, non-religious mental health watchdog. Its mission is to eradicate abuses committed under the guise of mental health and enact patient and consumer protections. CCHR has helped to enact more than 150 laws protecting individuals from abusive or coercive mental health practices.

--

[1] Lindsey Tanner, "STUDY: PSYCH DRUG ER TRIPS APPROACH 90,000 A YEAR," Associated Press, July 9, 2014, bigstory.ap.org/article/study-psych-drug-er-trips-approach-90000-year-0.

[2] Lindsey Tanner, "STUDY: PSYCH DRUG ER TRIPS APPROACH 90,000 A YEAR," Associated Press, July 9, 2014, bigstory.ap.org/article/study-psych-drug-er-trips-approach-90000-year-0; Sabriya Rice, “Nearly 90,000 ED visits annually linked to psychiatric drug events,” Modern Healthcare, 3 Sept. 2014, modernhealthcare.com/article/20140903/NEWS/309039964.

[3] Lee M. Hampton, MD, MSc, et al., “Emergency Department Visits by Adults for Psychiatric Medication Adverse Events,” JAMA Psychiatry, 9 July 2014, ncbi.nlm.nih.gov/pubmed/25006837.

[4] IMS, Vector One: National (VONA) and Total Patient Tracker (TPT) Database, Year 2013, Extracted June 2014.

[5] "The Adverse Event Reporting System (AERS): Older Quarterly Data Files," U.S. Food and Drug Administration, fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/AdverseDrugEffects/ucm083765.htm.

[6] David A. Kessler, MD, “Introducing MEDWatch A New Approach to Reporting Medication and Device Adverse Effects and Product Problems,” JAMA, 2 June 1993, Vol. 269, No. 21, pp. 2765-2768, fda.gov/downloads/Safety/MedWatch/UCM201419.pdf.

[7] International warnings compiled from the US FDA, fda.gov/Safety/MedWatch; Health Canada, hc-sc.gc.ca/index-eng.php; Japan Ministry of Health, Labour and Welfare, mhlw.go.jp/english/; Australia’s Therapeutic Goods Administration, tga.gov.au; UK’s Medicines and Healthcare products Regulatory Agency, mhra.gov.uk/; New Zealand's Medsafe, medsafe.govt.nz/; Irish Medicines Board, imb.ie/; South Africa's Medicines Control Council, sanctr.gov.za/YourRights/TheMedicinesControlCouncil/tabid/176/Default.aspx.

Media Department, Citizens Commission on Human Rights, http://www.cchrint.org, +1 (323) 467-4242, [email protected]

Modal title

CCHR's drug database provides a wealth of information, including adverse side effects, the number of studies showing adverse effects of specific drugs and the FDA's data on adverse drug events.
CCHR's drug database provides a wealth of information, including adverse side effects, the number of studies showing adverse effects of specific drugs and the FDA's data on adverse drug events.
According to the FDA, between 2004 and 2012, there were more than five hundred thousand adverse reactions from psychiatric drugs reported to the federal agency.
According to the FDA, between 2004 and 2012, there were more than five hundred thousand adverse reactions from psychiatric drugs reported to the federal agency.
CCHR's drug database provides a wealth of information, including adverse side effects, the number of studies showing adverse effects of specific drugs and the FDA's data on adverse drug events. According to the FDA, between 2004 and 2012, there were more than five hundred thousand adverse reactions from psychiatric drugs reported to the federal agency.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.